A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis
Clinical trial NCT05601778 · COMPLETED
Trial details
- NCT number
- NCT05601778
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-06
- Primary completion
- 2024-03-29
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.